Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
50%
Ph phase_4
1
25%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_2

Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE

NCT05762146
completedphase_3

Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis

NCT05118542
completedphase_3

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

NCT01436994
unknownphase_4

The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy

NCT01056419

Clinical Trials (4)

Showing 4 of 4 trials
NCT05762146Phase 2

Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE

Unknown
NCT05118542Phase 3

Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis

Completed
NCT01436994Phase 3

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

Completed
NCT01056419Phase 4

The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4